Liposome Drug Delivery Market Scope And Analysis

  • Report Code : TIPRE00010407
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Liposome Drug Delivery Market Report - Analysis by 2031

Buy Now

Liposome Drug Delivery Market Report Liposome Drug Delivery Market Size and Share Liposome Drug Delivery Market Scope and Analysis

Liposome Drug Delivery Market Report Scope

Report Attribute Details
Market size in 2021 US$ 4.2 Billion
Market Size by 2031 US$ 11.5 Billion
Global CAGR (2023 - 2031) 8.3%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Product
  • Liposomal Doxorubicin
  • Liposomal Paclitaxel
  • Liposomal Amphotericin B
By Technology
  • Stealth Liposome Technology
  • Non-PEGylated Liposome Technology
  • DepoFoam Liposome Technology
  • Lysolipid Thermally Sensitive Liposome
By Application
  • Fungal Diseases
  • Cancer Therapy
  • Pain Management
  • Viral Vaccines
  • Photodynamic Therapy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Takeda Pharmaceutical Company Limited
  • Novartis
  • Luye Pharma Group
  • Ipsen Pharma
  • CELSION Inc
  • Astellas Pharma Inc
  • Johnson Johnson Services Inc
  • Acrotech Biopharma Inc
  • Gilead Sciences Inc
  • Sun Pharmaceuticals